George N Konstantinou, William C Anderson, Evangelos Bagkis, Zoe Brown, Kostas Karatzas, Theodosios Kassandros, Chrysanthi Sardeli, Ruchi Singla, Sharmilee M Nyenhuis
{"title":"人工智能驱动的可穿戴和连接过敏技术:个性化护理的实时监测和预测管理。","authors":"George N Konstantinou, William C Anderson, Evangelos Bagkis, Zoe Brown, Kostas Karatzas, Theodosios Kassandros, Chrysanthi Sardeli, Ruchi Singla, Sharmilee M Nyenhuis","doi":"10.1016/j.jaip.2025.09.013","DOIUrl":null,"url":null,"abstract":"<p><p>Allergic diseases are increasing worldwide, underscoring the need for innovative management strategies. Wearable and connected technologies combined with artificial intelligence (AI) can support real-time monitoring, personalized alerts, and proactive interventions. This review summarizes AI-enabled tools for allergy care spanning physiologic signals, environmental exposures (e.g., pollutant proxies such as particulates/VOCs), and patient behaviors, as well as connected medication-adherence technologies (e.g., digital inhalers) that integrate with the same analytics workflows. We also outline predictive algorithms that forecast exacerbations and briefly review therapeutic devices. Reported benefits include earlier warning of clinical deterioration, improved adherence/technique, and opportunities for tailored management. However, important limitations remain around data accuracy and reliability, user adoption, workflow integration, equity/fairness, privacy/cybersecurity, and evolving regulatory pathways. Critically, most devices and algorithms reviewed are investigational or early-phase, with evidence dominated by feasibility or short-term studies, and only a few show improvements in patient-centered outcomes in prospective trials. Realizing clinical value will require outcomes-focused validation (including external/pragmatic studies), safeguards for privacy and security, attention to bias and subgroup performance, and implementation models that fit clinical workflows and reimbursement. With these conditions met, AI-driven wearable and connected technologies could enable more proactive, personalized allergy care.</p>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":" ","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AI-Driven Wearable and Connected Technology for Allergy: Real-Time Monitoring and Predictive Management for Personalized Care.\",\"authors\":\"George N Konstantinou, William C Anderson, Evangelos Bagkis, Zoe Brown, Kostas Karatzas, Theodosios Kassandros, Chrysanthi Sardeli, Ruchi Singla, Sharmilee M Nyenhuis\",\"doi\":\"10.1016/j.jaip.2025.09.013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Allergic diseases are increasing worldwide, underscoring the need for innovative management strategies. Wearable and connected technologies combined with artificial intelligence (AI) can support real-time monitoring, personalized alerts, and proactive interventions. This review summarizes AI-enabled tools for allergy care spanning physiologic signals, environmental exposures (e.g., pollutant proxies such as particulates/VOCs), and patient behaviors, as well as connected medication-adherence technologies (e.g., digital inhalers) that integrate with the same analytics workflows. We also outline predictive algorithms that forecast exacerbations and briefly review therapeutic devices. Reported benefits include earlier warning of clinical deterioration, improved adherence/technique, and opportunities for tailored management. However, important limitations remain around data accuracy and reliability, user adoption, workflow integration, equity/fairness, privacy/cybersecurity, and evolving regulatory pathways. Critically, most devices and algorithms reviewed are investigational or early-phase, with evidence dominated by feasibility or short-term studies, and only a few show improvements in patient-centered outcomes in prospective trials. Realizing clinical value will require outcomes-focused validation (including external/pragmatic studies), safeguards for privacy and security, attention to bias and subgroup performance, and implementation models that fit clinical workflows and reimbursement. With these conditions met, AI-driven wearable and connected technologies could enable more proactive, personalized allergy care.</p>\",\"PeriodicalId\":51323,\"journal\":{\"name\":\"Journal of Allergy and Clinical Immunology-In Practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-10-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Allergy and Clinical Immunology-In Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jaip.2025.09.013\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaip.2025.09.013","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
AI-Driven Wearable and Connected Technology for Allergy: Real-Time Monitoring and Predictive Management for Personalized Care.
Allergic diseases are increasing worldwide, underscoring the need for innovative management strategies. Wearable and connected technologies combined with artificial intelligence (AI) can support real-time monitoring, personalized alerts, and proactive interventions. This review summarizes AI-enabled tools for allergy care spanning physiologic signals, environmental exposures (e.g., pollutant proxies such as particulates/VOCs), and patient behaviors, as well as connected medication-adherence technologies (e.g., digital inhalers) that integrate with the same analytics workflows. We also outline predictive algorithms that forecast exacerbations and briefly review therapeutic devices. Reported benefits include earlier warning of clinical deterioration, improved adherence/technique, and opportunities for tailored management. However, important limitations remain around data accuracy and reliability, user adoption, workflow integration, equity/fairness, privacy/cybersecurity, and evolving regulatory pathways. Critically, most devices and algorithms reviewed are investigational or early-phase, with evidence dominated by feasibility or short-term studies, and only a few show improvements in patient-centered outcomes in prospective trials. Realizing clinical value will require outcomes-focused validation (including external/pragmatic studies), safeguards for privacy and security, attention to bias and subgroup performance, and implementation models that fit clinical workflows and reimbursement. With these conditions met, AI-driven wearable and connected technologies could enable more proactive, personalized allergy care.
期刊介绍:
JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases.
This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders.
The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.